{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,5]],"date-time":"2026-09-05T21:18:22Z","timestamp":1788643102625,"version":"build-2803163510"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"7454","license":[{"start":{"date-parts":[[2013,5,29]],"date-time":"2013-05-29T00:00:00Z","timestamp":1369785600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nature"],"published-print":{"date-parts":[[2013,6]]},"DOI":"10.1038\/nature12204","type":"journal-article","created":{"date-parts":[[2013,5,28]],"date-time":"2013-05-28T16:20:09Z","timestamp":1369758009000},"page":"325-331","source":"Crossref","is-referenced-by-count":130,"title":["RAS\u2013MAPK\u2013MSK1 pathway modulates ataxin 1 protein levels and toxicity in SCA1"],"prefix":"10.1038","volume":"498","author":[{"given":"Jeehye","family":"Park","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ismael","family":"Al-Ramahi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiumin","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nissa","family":"Mollema","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Javier R.","family":"Diaz-Garcia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatiana","family":"Gallego-Flores","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hsiang-Chih","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarita","family":"Lagalwar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa","family":"Duvick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyojin","family":"Kang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoontae","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paymaan","family":"Jafar-Nejad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Layal S.","family":"Sayegh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronald","family":"Richman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiuyun","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chad A.","family":"Shaw","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. Simon C.","family":"Arthur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harry T.","family":"Orr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas F.","family":"Westbrook","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan","family":"Botas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huda Y.","family":"Zoghbi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2013,5,29]]},"reference":[{"key":"BFnature12204_CR1","doi-asserted-by":"publisher","first-page":"267","DOI":"10.2307\/3350099","volume":"68","author":"DA Evans","year":"1990","unstructured":"Evans, D. A. Estimated prevalence of Alzheimer\u2019s disease in the United States. Milbank Q. 68, 267\u2013289 (1990)","journal-title":"Milbank Q."},{"key":"BFnature12204_CR2","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1093\/ageing\/afp223","volume":"39","author":"JV Hindle","year":"2010","unstructured":"Hindle, J. V. Ageing, neurodegeneration and Parkinson\u2019s disease. Age Ageing 39, 156\u2013161 (2010)","journal-title":"Age Ageing"},{"key":"BFnature12204_CR3","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1016\/S0140-6736(77)91146-1","volume":"1","author":"CD Marsden","year":"1977","unstructured":"Marsden, C. D. & Parkes, J. D. Success and problems of long-term levodopa therapy in Parkinson\u2019s disease. Lancet 1, 345\u2013349 (1977)","journal-title":"Lancet"},{"key":"BFnature12204_CR4","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1016\/S1474-4422(03)00502-7","volume":"2","author":"E Scarpini","year":"2003","unstructured":"Scarpini, E., Scheltens, P. & Feldman, H. Treatment of Alzheimer\u2019s disease: current status and new perspectives. Lancet Neurol. 2, 539\u2013547 (2003)","journal-title":"Lancet Neurol."},{"key":"BFnature12204_CR5","doi-asserted-by":"publisher","first-page":"S10","DOI":"10.1038\/nm1066","volume":"10","author":"CA Ross","year":"2004","unstructured":"Ross, C. A. & Poirier, M. A. Protein aggregation and neurodegenerative disease. Nature Med. 10, S10\u2013S17 (2004)","journal-title":"Nature Med."},{"key":"BFnature12204_CR6","doi-asserted-by":"publisher","first-page":"1991","DOI":"10.1126\/science.1067122","volume":"296","author":"JP Taylor","year":"2002","unstructured":"Taylor, J. P., Hardy, J. & Fischbeck, K. H. Toxic proteins in neurodegenerative disease. Science 296, 1991\u20131995 (2002)","journal-title":"Science"},{"key":"BFnature12204_CR7","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1038\/nrm2101","volume":"8","author":"C Haass","year":"2007","unstructured":"Haass, C. & Selkoe, D. J. Soluble protein oligomers in neurodegeneration: lessons from the Alzheimer\u2019s amyloid \u03b2-peptide. Nature Rev. Mol. Cell Biol. 8, 101\u2013112 (2007)","journal-title":"Nature Rev. Mol. Cell Biol."},{"key":"BFnature12204_CR8","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1146\/annurev.neuro.23.1.217","volume":"23","author":"HY Zoghbi","year":"2000","unstructured":"Zoghbi, H. Y. & Orr, H. T. Glutamine repeats and neurodegeneration. Annu. Rev. Neurosci. 23, 217\u2013247 (2000)","journal-title":"Annu. Rev. Neurosci."},{"key":"BFnature12204_CR9","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1126\/science.1090278","volume":"302","author":"AB Singleton","year":"2003","unstructured":"Singleton, A. B. et al. \u03b1-synuclein locus triplication causes Parkinson\u2019s disease. Science 302, 841 (2003)","journal-title":"Science"},{"key":"BFnature12204_CR10","doi-asserted-by":"publisher","first-page":"1167","DOI":"10.1016\/S0140-6736(04)17103-1","volume":"364","author":"MC Chartier-Harlin","year":"2004","unstructured":"Chartier-Harlin, M. C. et al. \u03b1-synuclein locus duplication as a cause of familial Parkinson's disease. Lancet 364, 1167\u20131169 (2004)","journal-title":"Lancet"},{"key":"BFnature12204_CR11","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1038\/ng1718","volume":"38","author":"A Rovelet-Lecrux","year":"2006","unstructured":"Rovelet-Lecrux, A. et al. APP locus duplication causes autosomal dominant early-onset Alzheimer disease with cerebral amyloid angiopathy. Nature Genet. 38, 24\u201326 (2006)","journal-title":"Nature Genet."},{"key":"BFnature12204_CR12","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1038\/nrn2420","volume":"9","author":"J G\u00f6tz","year":"2008","unstructured":"G\u00f6tz, J. & Ittner, L. M. Animal models of Alzheimer\u2019s disease and frontotemporal dementia. Nature Rev. Neurosci. 9, 532\u2013544 (2008)","journal-title":"Nature Rev. Neurosci."},{"key":"BFnature12204_CR13","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1016\/j.tins.2008.07.004","volume":"31","author":"AJ Williams","year":"2008","unstructured":"Williams, A. J. & Paulson, H. L. Polyglutamine neurodegeneration: protein misfolding revisited. Trends Neurosci. 31, 521\u2013528 (2008)","journal-title":"Trends Neurosci."},{"key":"BFnature12204_CR14","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1038\/nm1076","volume":"10","author":"H Xia","year":"2004","unstructured":"Xia, H. et al. RNAi suppresses polyglutamine-induced neurodegeneration in a model of spinocerebellar ataxia. Nature Med. 10, 816\u2013820 (2004)","journal-title":"Nature Med."},{"key":"BFnature12204_CR15","doi-asserted-by":"publisher","first-page":"5820","DOI":"10.1073\/pnas.0501507102","volume":"102","author":"SQ Harper","year":"2005","unstructured":"Harper, S. Q. et al. RNA interference improves motor and neuropathological abnormalities in a Huntington\u2019s disease mouse model. Proc. Natl Acad. Sci. USA 102, 5820\u20135825 (2005)","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnature12204_CR16","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/S0092-8674(00)80623-6","volume":"101","author":"A Yamamoto","year":"2000","unstructured":"Yamamoto, A., Lucas, J. J. & Hen, R. Reversal of neuropathology and motor dysfunction in a conditional model of Huntington\u2019s disease. Cell 101, 57\u201366 (2000)","journal-title":"Cell"},{"key":"BFnature12204_CR17","doi-asserted-by":"publisher","first-page":"8853","DOI":"10.1523\/JNEUROSCI.2978-04.2004","volume":"24","author":"T Zu","year":"2004","unstructured":"Zu, T. et al. Recovery from polyglutamine-induced neurodegeneration in conditional SCA1 transgenic mice. J. Neurosci. 24, 8853\u20138861 (2004)","journal-title":"J. Neurosci."},{"key":"BFnature12204_CR18","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.1016\/j.neuron.2012.05.009","volume":"74","author":"HB Kordasiewicz","year":"2012","unstructured":"Kordasiewicz, H. B. et al. Sustained therapeutic reversal of Huntington\u2019s disease by transient repression of huntingtin synthesis. Neuron 74, 1031\u20131044 (2012)","journal-title":"Neuron"},{"key":"BFnature12204_CR19","doi-asserted-by":"publisher","first-page":"7425","DOI":"10.1074\/jbc.R800041200","volume":"284","author":"HY Zoghbi","year":"2009","unstructured":"Zoghbi, H. Y. & Orr, H. T. Pathogenic mechanisms of a polyglutamine-mediated neurodegenerative disease, spinocerebellar ataxia type 1. J. Biol. Chem. 284, 7425\u20137429 (2009)","journal-title":"J. Biol. Chem."},{"key":"BFnature12204_CR20","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1016\/S0896-6273(03)00258-7","volume":"38","author":"ES Emamian","year":"2003","unstructured":"Emamian, E. S. et al. Serine 776 of ataxin-1 is critical for polyglutamine-induced disease in SCA1 transgenic mice. Neuron 38, 375\u2013387 (2003)","journal-title":"Neuron"},{"key":"BFnature12204_CR21","doi-asserted-by":"publisher","first-page":"1800","DOI":"10.1126\/science.1095920","volume":"303","author":"ME Noble","year":"2004","unstructured":"Noble, M. E., Endicott, J. A. & Johnson, L. N. Protein kinase inhibitors: insights into drug design from structure. Science 303, 1800\u20131805 (2004)","journal-title":"Science"},{"key":"BFnature12204_CR22","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1038\/35040584","volume":"408","author":"P Fernandez-Funez","year":"2000","unstructured":"Fernandez-Funez, P. et al. Identification of genes that modify ataxin-1-induced neurodegeneration. Nature 408, 101\u2013106 (2000)","journal-title":"Nature"},{"key":"BFnature12204_CR23","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1038\/nrm1837","volume":"7","author":"CM Taniguchi","year":"2006","unstructured":"Taniguchi, C. M., Emanuelli, B. & Kahn, C. R. Critial nodes in signalling pathways: insights into insulin action. Nature Rev. Mol. Cell Biol. 7, 85\u201396 (2006)","journal-title":"Nature Rev. Mol. Cell Biol."},{"key":"BFnature12204_CR24","doi-asserted-by":"publisher","first-page":"1631","DOI":"10.1111\/j.1742-4658.2008.06318.x","volume":"275","author":"M Shaharabany","year":"2008","unstructured":"Shaharabany, M. et al. Distinct pathways for the involvement of WNK4 in the signaling of hypertonicity and EGF. FEBS J. 275, 1631\u20131642 (2008)","journal-title":"FEBS J."},{"key":"BFnature12204_CR25","doi-asserted-by":"publisher","first-page":"2996","DOI":"10.1093\/hmg\/ddr203","volume":"20","author":"A Teixeira-Castro","year":"2011","unstructured":"Teixeira-Castro, A. et al. Neuron-specific proteotoxicity of mutant ataxin-3 in C.  elegans: rescue by the DAF-16 and HSF-1 pathways. Hum. Mol. Genet. 20, 2996\u20133009 (2011)","journal-title":"Hum. Mol. Genet."},{"key":"BFnature12204_CR26","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1016\/S0079-6107(98)00056-X","volume":"71","author":"MH Cobb","year":"1999","unstructured":"Cobb, M. H. MAP kinase pathways. Prog. Biophys. Mol. Biol. 71, 479\u2013500 (1999)","journal-title":"Prog. Biophys. Mol. Biol."},{"key":"BFnature12204_CR27","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1023\/A:1006823109415","volume":"182","author":"J Avruch","year":"1998","unstructured":"Avruch, J. Insulin signal transduction through protein kinase cascades. Mol. Cell. Biochem. 182, 31\u201348 (1998)","journal-title":"Mol. Cell. Biochem."},{"key":"BFnature12204_CR28","doi-asserted-by":"publisher","first-page":"e234","DOI":"10.1371\/journal.pgen.0030234","volume":"3","author":"I Al-Ramahi","year":"2007","unstructured":"Al-Ramahi, I. et al. dAtaxin-2 mediates expanded Ataxin-1-induced neurodegeneration in a Drosophila model of SCA1. PLoS Genet. 3, e234 (2007)","journal-title":"PLoS Genet."},{"key":"BFnature12204_CR29","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1111\/j.1471-4159.2009.06164.x","volume":"110","author":"ND Jorgensen","year":"2009","unstructured":"Jorgensen, N. D. et al. Phosphorylation of ATXN1 at Ser776 in the cerebellum. J. Neurochem. 110, 675\u2013686 (2009)","journal-title":"J. Neurochem."},{"key":"BFnature12204_CR30","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1128\/MMBR.68.2.320-344.2004","volume":"68","author":"PP Roux","year":"2004","unstructured":"Roux, P. P. & Blenis, J. ERK and p38 MAPK-activated protein kinases: a family of protein kinases with diverse biological functions. Microbiol. Mol. Biol. Rev. 68, 320\u2013344 (2004)","journal-title":"Microbiol. Mol. Biol. Rev."},{"key":"BFnature12204_CR31","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/S0014-5793(01)02651-5","volume":"502","author":"N Mody","year":"2001","unstructured":"Mody, N., Leitch, J., Armstrong, C., Dixon, J. & Cohen, P. Effects of MAP kinase cascade inhibitors on the MKK5\/ERK5 pathway. FEBS Lett. 502, 21\u201324 (2001)","journal-title":"FEBS Lett."},{"key":"BFnature12204_CR32","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/S0960-894X(99)00668-X","volume":"10","author":"K Lackey","year":"2000","unstructured":"Lackey, K. et al. The discovery of potent cRaf1 kinase inhibitors. Bioorg. Med. Chem. Lett. 10, 223\u2013226 (2000)","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"BFnature12204_CR33","doi-asserted-by":"publisher","first-page":"4426","DOI":"10.1093\/emboj\/17.15.4426","volume":"17","author":"M Deak","year":"1998","unstructured":"Deak, M., Clifton, A. D., Lucocq, L. M. & Alessi, D. R. Mitogen- and stress-activated protein kinase-1 (MSK1) is directly activated by MAPK and SAPK2\/p38, and may mediate activation of CREB. EMBO J. 17, 4426\u20134441 (1998)","journal-title":"EMBO J."},{"key":"BFnature12204_CR34","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1093\/hmg\/9.5.779","volume":"9","author":"D Lorenzetti","year":"2000","unstructured":"Lorenzetti, D. et al. Repeat instability and motor incoordination in mice with a targeted expanded CAG repeat in the Sca1 locus. Hum. Mol. Genet. 9, 779\u2013785 (2000)","journal-title":"Hum. Mol. Genet."},{"key":"BFnature12204_CR35","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1016\/S0896-6273(02)00733-X","volume":"34","author":"K Watase","year":"2002","unstructured":"Watase, K. et al. A long CAG repeat in the mouse Sca1 locus replicates SCA1 features and reveals the impact of protein solubility on selective neurodegeneration. Neuron 34, 905\u2013919 (2002)","journal-title":"Neuron"},{"key":"BFnature12204_CR36","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/S0014-5793(00)02031-7","volume":"482","author":"JS Arthur","year":"2000","unstructured":"Arthur, J. S. & Cohen, P. MSK1 is required for CREB phosphorylation in response to mitogens in mouse embryonic stem cells. FEBS Lett. 482, 44\u201348 (2000)","journal-title":"FEBS Lett."},{"key":"BFnature12204_CR37","doi-asserted-by":"publisher","first-page":"2871","DOI":"10.1128\/MCB.22.8.2871-2881.2002","volume":"22","author":"GR Wiggin","year":"2002","unstructured":"Wiggin, G. R. et al. MSK1 and MSK2 are required for the mitogen- and stress- induced phosphorylation of CREB and ATF1 in fibroblasts. Mol. Cell. Biol. 22, 2871\u20132881 (2002)","journal-title":"Mol. Cell. Biol."},{"key":"BFnature12204_CR38","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1016\/0092-8674(95)90273-2","volume":"82","author":"EN Burright","year":"1995","unstructured":"Burright, E. N. et al. SCA1 transgenic mice: a model for neurodegeneration caused by an expanded CAG trinucleotide repeat. Cell 82, 937\u2013948 (1995)","journal-title":"Cell"},{"key":"BFnature12204_CR39","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1038\/nature11127","volume":"486","author":"AC Dar","year":"2012","unstructured":"Dar, A. C., Das, T. K., Shokat, K. M. & Cagan, R. L. Chemical genetic discovery of targets and anti-targets for cancer polypharmacology. Nature 486, 80\u201384 (2012)","journal-title":"Nature"},{"key":"BFnature12204_CR40","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1002\/emmm.200900051","volume":"1","author":"TJ van Ham","year":"2009","unstructured":"van Ham, T. J., Breitling, R., Swertz, M. A. & Nollen, E. A. Neurodegenerative diseases: lessons from genome-wide screens in small model organisms. EMBO Mol. Med. 1, 360\u2013370 (2009)","journal-title":"EMBO Mol. Med."},{"key":"BFnature12204_CR41","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.cell.2009.03.018","volume":"137","author":"H Jeong","year":"2009","unstructured":"Jeong, H. et al. Acetylation targets mutant huntingtin to autophagosomes for degradation. Cell 137, 60\u201372 (2009)","journal-title":"Cell"},{"key":"BFnature12204_CR42","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1038\/sj.emboj.7600081","volume":"23","author":"M Matsumoto","year":"2004","unstructured":"Matsumoto, M. et al. Molecular clearance of ataxin-3 is regulated by a mammalian E4. EMBO J. 23, 659\u2013669 (2004)","journal-title":"EMBO J."},{"key":"BFnature12204_CR43","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1016\/S0896-6273(00)81035-1","volume":"24","author":"CJ Cummings","year":"1999","unstructured":"Cummings, C. J. et al. Mutation of the E6-AP ubiquitin ligase reduces nuclear inclusion frequency while accelerating polyglutamine-induced pathology in SCA1 mice. Neuron 24, 879\u2013892 (1999)","journal-title":"Neuron"},{"key":"BFnature12204_CR44","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1038\/nature06914","volume":"452","author":"L Chin","year":"2008","unstructured":"Chin, L. & Gray, J. W. Translating insights from the cancer genome into clinical practice. Nature 452, 553\u2013563 (2008)","journal-title":"Nature"},{"key":"BFnature12204_CR45","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1038\/nprot.2008.13","volume":"3","author":"J Falsig","year":"2008","unstructured":"Falsig, J. & Aguzzi, A. The prion organotypic slice culture assay\u2014POSCA. Nature Protocols 3, 555\u2013562 (2008)","journal-title":"Nature Protocols"},{"key":"BFnature12204_CR46","doi-asserted-by":"publisher","first-page":"2142","DOI":"10.1073\/pnas.1018748108","volume":"108","author":"P Jafar-Nejad","year":"2011","unstructured":"Jafar-Nejad, P., Ward, C. S., Richman, R., Orr, H. T. & Zoghbi, H. Y. Regional rescue of spinocerebellar ataxia type 1 phenotypes by 14\u20133-3 haploinsufficiency in mice underscores complex pathogenicity in neurodegeneration. Proc. Natl Acad. Sci. USA 108, 2142\u20132147 (2011)","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnature12204_CR47","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1038\/ng1977","volume":"39","author":"AB Bowman","year":"2007","unstructured":"Bowman, A. B. et al. Duplication of Atxn1l suppresses SCA1 neuropathology by decreasing incorporation of polyglutamine-expanded ataxin-1 into native complexes. Nature Genet. 39, 373\u2013379 (2007)","journal-title":"Nature Genet."},{"key":"BFnature12204_CR48","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1038\/nature06731","volume":"452","author":"J Lim","year":"2008","unstructured":"Lim, J. et al. Opposing effects of polyglutamine expansion on native protein complexes contribute to SCA1. Nature 452, 713\u2013718 (2008)","journal-title":"Nature"},{"key":"BFnature12204_CR49","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1038\/ng0595-94","volume":"10","author":"A Servadio","year":"1995","unstructured":"Servadio, A. et al. Expression analysis of the ataxin-1 protein in tissues from normal and spinocerebellar ataxia type 1 individuals. Nature Genet. 10, 94\u201398 (1995)","journal-title":"Nature Genet."}],"container-title":["Nature"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/nature12204.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nature12204","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nature12204.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T18:11:42Z","timestamp":1684433502000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/nature12204"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,5,29]]},"references-count":49,"journal-issue":{"issue":"7454","published-print":{"date-parts":[[2013,6]]}},"alternative-id":["BFnature12204"],"URL":"https:\/\/doi.org\/10.1038\/nature12204","relation":{},"ISSN":["0028-0836","1476-4687"],"issn-type":[{"value":"0028-0836","type":"print"},{"value":"1476-4687","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,5,29]]}}}